GARRETT KOEHN: Open Payments
NPI 1851041693 · COFFEYVILLE, KS. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$282 in 15 payments from 10 companies in 2025. Trend: 2023 $0 · 2024 $6 · 2025 $282
Food & beverage: $282
| Company | Payments | Amount |
|---|---|---|
| AstraZeneca Pharmaceuticals LP | 5 | $82 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 2 | $37 |
| Salix Pharmaceuticals, a division of Bausch Health US, LLC | 1 | $25 |
| Merck Sharp & Dohme LLC | 1 | $25 |
| GlaxoSmithKline, LLC. | 1 | $24 |
| Verona Pharma, Inc. | 1 | $21 |
| Novo Nordisk Inc | 1 | $20 |
| ABBVIE INC. | 1 | $18 |
| VERTEX PHARMACEUTICALS INCORPORATED | 1 | $16 |
| Bayer Healthcare Pharmaceuticals Inc. | 1 | $14 |
Products named: BREZTRI, CAPLYTA, XIFAXAN, CAPVAXIVE, TRELEGY ELLIPTA, FARXIGA, Ohtuvayre, Wegovy.
Industry payments across KS — which companies pay providers there.
